InMed Pharmaceuticals (INM) Q1 2025 Earnings

12FebConfirmed
Q4 2023
Q2 2024
Q4 2024
Q1 2025
-3.64
-2.49
-1.33
-0.18

Details

Expected EPS
N/A
Actual EPS
-3.64
Surprise EPS
-3.64
Surprise Percent
+∞%

Description

InMed Pharmaceuticals (INM) has reported earnings of -3.64 per share for Q1 2025.

0 Comments

Share your thoughts